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Résumé (français) 
Introduction : Les patients consultant leur médecin généraliste présentent fréquemment 
plusieurs problèmes ou états morbides. L'Organisation Mondiale de la Santé (OMS) définit 
simplement la multimorbidité comme l'existence de deux ou plusieurs atteintes chroniques 
chez un même patient. Cette définition ne parait pas appropriée à la démarche holistique de 
prise en charge globale du patient par le médecin généraliste. Grâce à une  revue systématique 
de la littérature, l'European General Practitioners Research Network (EGPRN) a produit une 
définition utilisable en pratique et en recherche de la multimorbidité. 
Objectif : L’objectif était de traduire cette définition dans plusieurs langues européennes, dont 
le bulgare. 
Méthode : Une procédure Delphi adaptée avec traduction Aller/Retour a été utilisée. Une 
traduction de l’Anglais au Bulgare a été soumise par procédure Delphi à un panel d’experts 
bulgares en soins primaires. La traduction retour a été réalisée en aveugle de l’original. 
Résultats : Le panel d’experts répond aux critères d’inclusion. La traduction Bulgare a été 
validée unanimement au premier tour. La traduction retour en anglais a été produite. 
Discussion : Le choix d’une méthode de traduction Aller/Retour par procédure Delphi adaptée 
avec exigence sur la qualité du panel d’experts, garantit une traduction bulgare de la definition 
de la multimorbidité  fiable.  
 
Summary (English) 
Introduction: Patients coming to their family physician (FP) usually have more than one 
condition or problem. The World Health Organization (WHO) has simply defined 
multimorbidity as two or more chronic conditions existing in one patient. However, this 
definition seems inadequate for a holistic approach to patient care within Family Medicine. 
Using systematic literature review the European General Practitioners Research Network 
(EGPRN) developed a comprehensive definition of multimorbidity.  
Objective: For practical and wider use, this definition had to be translated into other 
languages, including Bulgarian. 
Method: A Delphi method adapted for a Forward-Backward translation was used.  The 
translation from English to Bulgarian was submitted by Delphi procedure to a panel of 
Bulgarian experts in primary care. Backward translation was performed with a blind back-
translation principle. 
Results: The inclusion criteria of panel were kept. The Bulgarian translation was confirmed 
unanimously in one Delphi round. The Backward English translation was produced and 
agreed by the FPDM’s scientific committee. 
Discussion: The quality of the panel of experts FPs ensured a validated and reliable Bulgarian 
translation for the multimorbidity definition. 
Introduction 
 
The concept of multimorbidity was first published in 1976 in Germany (1) and remained 
almost entirely restricted to German publications for 14 years. Between 1976 and 1990 only 
72 articles used the term multimorbidity in their text, of which 66 were written in German. In 
1990 the concept became internationally recognized through research (2). 
 
The concept of multimorbidity was an addition to the concept of comorbidity. Comorbidity 
was defined as any disease or risk factors that could interact with one main disease with the 
effect of making it worse (3) (4) (5). Multimorbidity has been defined by the World Health 
Organization (WHO) as people being affected by two or more chronic health conditions (6). 
The intention of the WHO was to look at all conditions in one individual that could impact on 
that individual’s global health status. However the word ‘condition’ was not sufficiently clear 
for practical purposes (for instance, whether a treated disease was a ‘condition’ in this sense), 
and could lead to numerous interpretations.  
 
Multimorbidity is a particularly interesting concept for Family Practice, given the increasing 
prevalence of chronic illness in the aging population across developed countries. It is closely 
related to a global view of the patient, which is a core competency of Family Practice, as 
defined for instance by the World Organization of National Colleges, Academies and 
Academic Associations of General Practitioners/Family Physicians (WONCA) (7). 
Multimorbidity is an interesting concept, when applied to patients in practice, as it gives an 
overview of all the factors that could lead to frailty (8) (9). Frailty, however, is another new 
concept whose consensual definition is discussed further on (10) (11).  
 
Since the available, WHO definition of multimorbidity was inadequate for practical use 
because of its inaccuracy and because of existence of its various definitions in literature. Thus 
a new, clear and more comprehensive definition has been enhanced by the European General 
Practice Research Network (EGPRN) workgroup (12). The main aim of the whole project was 
to achieve a more usable definition of multimorbidity in order to advance research in this field 
throughout Europe. This kind of definition would greatly help researchers in Family Practice 
to investigate the complexity of patients’ conditions and their overall impact on patients’ 
health. Also, it could be an additional tool for Family Physicians (Fps) which would enable 
them to identify frail patients and work on the prevention of their decompensation.  
 
A research team, including 9 national groups, all-active within the EGPRN, has created a 
research community for the purpose of clarifying the concept of multimorbidity for FM 
throughout Europe (13). An initial review, presented in an EGPRN meeting in spring 2011 
(14), identified more than one hundred different definitions used by academic researchers. 
Such a large number of definitions added more confusion than clarification to the discussion. 
It led the group to the production of a comprehensive definition of multimorbidity through a 
systematic review of literature, in which all multimorbidity criteria were scanned and 
classified by theme (15). That comprehensive definition of multimorbidity was published after 
a careful check of its wording and meaning by a working group of three MD researchers from 
the Irish College of General Practitioners, an MD researcher from the Malta College of 
Family Doctors and two native English speaking official translators from the University of 
Brest (France) (15).  
This definition had then to be translated into most European languages for use in further  
collaborative research. It has been previously demonstrated that translating definitions, index  
or scales is a risky task in medical science (16). The aim of this article was to achieve the 
Bulgarian version of this definition . 
Method 
 
1. Definition 
 
Original definition achieved by EGPRN team was: Multimorbidity is defined as any 
combination of chronic disease with at least another disease (acute or chronic) or a bio 
psychosocial factor (associated or not) or a risk factor. Any bio psychosocial factor, any risk 
factor, the social network, the burden of diseases, the health care consumption and the 
patient’s coping strategies may function as modifiers. Multimorbidity may modify the health 
outcomes and lead to an increased disability or a decreased quality of life or frailty. 
 
2. Translation 
 
For the translation to retain the same meaning as the original, a Forward-Backward translation 
was conducted following a formal consensus method: Delphi method. Formal consensus is the 
most appropriate method for  little investigated subject. Delphi method, reliable and efficient 
is used frequently in health care to reach consensus in defined clinical areas(17) (18). It is a 
systematic interactive method which involves a panel of experts using iterative procedures. It 
can be done quickly to make a single convergent final recommendation. This process requires 
following four rules: anonymity of participants (ensures responses reliability and avoids 
contamination), iteration (allows participants to refine their views in the light of the progress 
of the group's work), control feedback (under the responsibility of national investigator (NI)), 
statistical aggregation of group’s responses to allow a quantitative and qualitative analysis of 
the data. 
 
 
3. Consents and anonymity 
The NI asked the participants for their signed consent, anonymized the expert responses and 
delivered an identification number later identification. The name of each expert was not 
transmitted to other. Only NI’s consent was sent to the investigator team. As the study 
involved no patient, it did not require an ethics committee‘s decision. 
 
 
4. Participants 
Pilot Team (PT): The EGPRN French team was familiar with Delphi methodology. It 
requested to the national investigator his consent and voluntary participation in the study and 
an absence of conflict of interest. It ensured that the whole process followed the protocol. It 
did not took part in the translation phases or in Delphi rounds. The Forward-Backward 
translation had to be validated by the daily board of the study, composed of members of the 
European General Practice Research Network (EGPRN) all active within the research 
process. 
 
National Investigator (NI): The NI was in charge of recruiting translators and experts. He 
acted between each phase and between two Delphi rounds. He did not act when a Delphi 
round was running. 
 
Translators: The NI selected four translators to make up two translation teams. Translators 
had to be knowledgeable about health care terminology. The forward translation team 
involved one member of the FP’s research group and one official translator. Bulgarian had to 
be their native language. The Backward translation team involved one (or two) FP(s) and one 
official Bulgarian/English translator. The two teams should not have involved the same 
person. 
 
Experts panel: Initially, 20 to 30 experts were recruited in order to keep at least 15 
participants until every round’s end. The selection criteria for every expert were: being native 
to Bulgaria and Bulgarian was his mother tongue; being English speaker; being in FP practice. 
Over half had to have teaching or research activities. In order to assess the representativeness 
of the panel by its diversity, the experts informed their gender, area of practice, years of 
practice and publications. 
 
 
5. Forward Translation  
The PT sent the multi-morbidity original English definition to the NI who sent it to the 
forward translation team. This team translated multi-morbidity definition from English to 
Bulgarian aiming to retain the same meaning as the original. 
 
 
6. Delphi rounds  
At the beginning of the first round, NI sent by mail the original English version and the 
translated version in Bulgarian. Fps experts received records individually. NI did not use 
mailing list in order to assure anonymity which increased responses reliability and to avoid 
contamination (discussion between experts). 
 Experts expressed their level of agreement on each proposal by using a Likert scale. This 
Likert scale was an agree/disagree scale of 1 to 9, symmetric, odd, that measured the intensity 
of their feelings on each proposal, taking into account the maintenance of the meaning 
between the original and the translation proposal, the ergonomics and the ease of 
understanding. Experts rated the proposal from 1 (absolutely no agreement) to 9 (fully 
agreement) and had to comment when rating less than 7. They were not aware of the 
following interpretation of data processing. Consensus was defined for an excerpt’s 
translation when it was rated 7 or above by over 70% of the panel, so it was accepted directly 
and did not enter the following rounds : this definition 
 of consensus in a Delphi round is the strongest possible definition, according to the Delphi 
 methods, and the RAND UCLA method that is a modified Delphi technique 
(19) (20). If proposal did not reach consensus, the NI and the forward official translator 
synthesized experts’ comments to propose a new translation proposal for this excerpt. Time 
between two rounds had to be less than four weeks. The following round began when the NI 
sent to the experts separately for each excerpt that did not reach consensus: the original 
English version, the unaccepted proposal, all the experts’ commented on this proposal, the 
new proposal. Experts rated the new proposal in the same way as for the first round. The 
following rounds rolled out in an identical manner. This process was repeated until all 
excerpts find a consensual translation. The number of rounds was not limited. 
At the Delphi process end, there was a consensus on a final Bulgarian definition of multi-
morbidity. 
 
7. Backward translation 
NI sent the final Bulgarian version of multi-morbidity definition to the backward translation 
team who had to translate it into English. The translators should not have the knowledge of 
the original version (blind-back translation principle). Finally, he sent the Backward English 
version to the PT.   
Results 
 
1. Forward 
The NI submitted the questionnaire to one official translator and one FP researcher. A 
consensual forward translation of multimorbidity definition was proposed (table 2).  The 
native language of translators was Bulgarian and they were knowledgeable about health care 
terminology. 
 
2. Panel 
The NI had particularly sought to obtain the consents of experts as well as the characteristics 
of each (table 1). 
Thirty FPs were recruited for the Delphi Process. They were all FPs in family practice. The 
experts consisted of 36,67 % male and 63,33 % female. Their age was distributed as follows: 
Between 20-30, 2,33%; 30-40, 10%; 40-50, 40%; 50-60, 40% ; 60-70, 3,33 %, with average 
age of 47,03 years. 
The expert’s level of English was evaluated. Among the 30 FPs, 16,67% were basic users, 
46,67% independent and 36,67% proficient.  
Clinical experience was analyzed by year of activities: 0-10 years (6,67%); 11-20 26;67%; 
20-30 40%; 30-40 3,33%, with average tear of activities of 21,8 years. 
Among the 30 FPs experts, 16,67 % had publications, 80 % of them had publications both in 
English and Bulgarian. The others worked in general medical practice.  
 
3. Delphi Process 
The NI oversaw but did not take part of the rounds. The NI had also conformed to the 
procedure of the Delphi round: the proposed translation was sent to the experts, using a Likert 
scale in 9 points, in separated mails.  There was only one Delphi round to validate the 
Bulgarian forward of multi-morbidity definition. 
The definition was validated with 7 or above by 29 experts, only 1 expert rated the definition 
at 6. Bulgarian definition was rated by 7 or above by over 70 % of the experts panel. 
6 experts had given comments for statements. 3 of them are related to the term « frailty ». 3 of 
them were grammatical rewording suggestions. 1 expert have found the definition too heavy 
and cumbersome. 
Bulgarian definition was accepted directly at the first round. 
 
4. Backward 
The Bulgarian version obtained was translated in English by two independents translators, 
which gave us one backward blind translation (table 3). The native language of the second 
translator was Bulgarian and he was knowledgeable about health care terminology. 
 
 
 
 
 
 
 
 
 
Table 1. Expert Panel Characteristics 
 
 
 
 
Gender
Age
English Level
A Basic User
M Male B Independent
F Female C Proficient
1 M 45 18 B 0 0 9
2 M 40 16 C 3 10 9
3 F 52 27 B 0 0 9
4 F 53 29 A 0 0 7
5 F 57 32 A 0 0 6
6 F 57 30 B 0 0 9
7 F 37 14 B 0 0 9
8 M 48 22 A 0 0 9
9 M 55 20 B 0 0 8
10 F 44 20 B 0 0 9
11 M 40 15 B 0 0 8
12 F 53 31 A 0 0 9
13 F 48 24 B 0 0 8
14 F 51 26 A 0 0 8
15 F 48 22 A 0 0 8
16 F 51 26 B 2 3 8
17 M 45 20 B 0 0 8
18 M 39 14 B 0 4 9
19 F 42 17 B 0 0 8
20 M 55 35 C 0 0 9
21 F 29 4 C 1 1 8
22 M 55 28 C 2 4 9
23 F 47 23 C 0 0 7
24 F 28 4 B 0 0 8
25 F 39 15 B 0 0 7
26 M 41 15 A 0 0 8
27 F 44 22 A 0 0 8
28 F 54 29 A 0 0 8
29 M 51 26 A 0 0 8
30 F 63 30 A 0 0 8
Participant
Number
Years in
 Practice
English
 Publications
Other
Publications
Lickert
Result
First round
Table 2. English Original and Bulgarian definition 
 
English original NATIVE proposed last round 
Multimorbidity is defined as any combination of 
chronic disease with at least one other disease (acute 
or chronic) or bio-psychosocial factor (associated or 
not) or somatic risk factor. 
 
 
Any bio-psychosocial factor, any somatic risk factor, 
the social network, the burden of diseases, the health 
care consumption and the patient’s coping strategies 
may function as modifiers (of the effects of 
Multimorbidity).  
 
 
Multimorbidity may modify the health outcomes and 
lead to an increased disability or a decreased quality 
of life or frailty. 
 
Полиморбидност се определя като всяка 
комбинация от хронично заболяване, с поне едно 
друго заболяване (остро или хронично) или свързан 
или не със заболяването био-психо-социален 
фактор или друг соматичен рисков фактор. 
Всеки био-психо-социален фактор, всеки рисков 
фактор, социалната среда, тежестта на 
заболяванията, използването на здравни услуги и 
стратегии на пациента за справяне могат да оказват 
влияние върху ефектите на полиморбидността. 
Полиморбидността може да доведе до промяна на 
очакваните резултати и до по-висока степен на 
инвалидност, понижено качество на живот или 
слабост. 
 
 
Table 3. Original English definition and the backward definition 
 
English original NATIVE back translation to English 
Multimorbidity is defined as any combination of 
chronic disease with at least one other disease (acute 
or chronic) or bio-psychosocial factor (associated or 
not) or somatic risk factor. 
 
Any bio-psychosocial factor, any somatic risk factor, 
the social network, the burden of diseases, the health 
care consumption and the patient’s coping strategies 
may function as modifiers (of the effects of 
Multimorbidity).  
 
Multimorbidity may modify the health outcomes and 
lead to an increased disability or a decreased quality 
of life or frailty. 
 
Multimorbidity is defined as any combination of a 
chronic disease combined with at least one other 
disease (acute or chronic) or bio-psychosocial factor 
(connected or not with the disease) or somatic risk 
factor. 
Any bio-psychosocial factor, any risk factor, the social 
environment, the burden of the diseases, the health care 
consumption and the patient’s strategies for coping 
may modify the effects of multimorbidity. 
 
Multimorbidity can lead to a change of the health 
outcomes and to a higher level of disability, decreased 
quality of life or frailty. 
Discussion 
 
The cross-cultural approach was complex. It integrated understanding of a cultural, linguistic 
and ethnic background. 
This methodological approach was focused on translation, adaptation and cross-validation of 
the multimorbidity definition in Bulgarian.  
 
Some articles were added to the original translation (“a chronic disease” instead of “chronic 
disease”) with the same meaning. The group concluded that there was no change in meaning. 
There was a change concerning ‘connection’ instead of ‘association’ (bio psychosocial factors 
“connected or not with the disease” instead of “associated or not with the disease”). But there 
is only one word in Bulgarian to express those two meanings and the group concluded that 
there was no change of meaning. The “somatic risk factors” were changed to “risk factors” as 
risk factors are always understood as somatic by Bulgarian FPs. « Network was changed into 
‘social network’, when describing the patient’s environment, to be sure the concept was as 
broad as in the original English definition. In this way, they encompassed, in Bulgarian, not 
only family and friends (which is the meaning of network in Bulgarian) but also the social 
infrastructures surrounding the patient, as was intended in English.  « May modify the health 
outcomes » was modified to “Multimorbidity can lead to a change in the health outcomes”. 
This phrasing is less emphatic than the original. Nevertheless, the research group did not think 
that the meaning was radically changed and kept the Bulgarian version.  
 
The Forward-Backward was achieved according with protocol. The power of the study was 
based on its methodology (Delphi process) and the selection of FPs experts. Experts was 
sufficient (30 FPS) according Delphi procedure. Panel was varied. Sample was reasoned 
according to gender, age and area of practice. Each expert was competent in English.  
The Delphi process with FPs experts aimed to evaluate the Bulgarian’s translation and 
integrate idiomatic expressions, colloquial health phrase and emotional terms in common use. 
Each expert expressed his judgment individually and anonymously. The lack of face-to-face 
meeting avoided the " opinion leader " effect and limits conflicts of interest. The procedure 
allowed to evaluate a question quickly and cheaply without geographical constraints.  
The forward translation was confirmed unanimously in one Delphi round in two weeks. This 
allowed absence of attrition bias. 
The Likert scale is an international validated, qualitative and ordinal scale. The ranking 7 or 
above guaranteed an adherence to the translation. 
Forward/Backward is an international validated process of translation and adaptation of 
instruments. The Forward translation process aimed to respect the faithfulness of meaning in 
English and Bulgarian. A specific careful was paid to choose FPs researcher and certified 
bilingual translator knowledgeable about health care terminology.   
 
In order to reduce bias: 
Confusion bias: to ensure homogeneity,, a back translation was necessary. The back translator 
was working blind and was an academic official translator. 
Information bias: The NI was a Family Physician invested in EGPRN, was FPs researcher and 
was the organizer of the Delphi round according to protocol. At each step of the protocol, the 
NI transmitted the results to the pilot team. In addition, every six months, the EGPRN team 
met to ensure the lowering of the information bias.  
Selection bias: All type of FPs (according to the sample’s characteristics) were represented. 
Conclusion 
 
The translation, adaptation and validation of an instrument for cross-cultural research required 
a rigorous methodological approach. The translation realized in Bulgaria obtained a consensus 
with one round Delphi unanimously approved. A meta-ethnographic study will verify its 
validity, ensuring that the meaning of every translation remains the same compared to the 
original English version. 
The implementation of the new definition is intended to help European FPs to identify 
multimorbid patients. It could be useful for other long-term care physicians like geriatricians. 
It could also be of importance to  policy makers to plan an optimal management of  
 patients, and to lower the burden of multimorbidity. 
This definition could be useful for teaching. It provides an overview of the subject in 
opposition to classical approach organ by organ. The European translations enable the 
EGPRN research team to proceed to the next step, 
 which is qualitative research, in order to find the value added by FPs to the concept of multi- 
morbidity. 
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ABSTRACT: 
 
Introduction : Les patients consultant leur médecin généraliste présentent fréquemment plusieurs problèmes ou 
états morbides. L'Organisation Mondiale de la Santé (OMS) définit simplement la multimorbidité comme 
l'existence de deux ou plusieurs atteintes chroniques chez un même patient. Cette définition ne parait pas 
appropriée à la démarche holistique de prise en charge globale du patient par le médecin généraliste. Grâce à une  
revue systématique de la littérature, l'European General Practitioners Research Network (EGPRN) a produit une 
définition utilisable en pratique et en recherche de la multimorbidité. 
Objectif : L’objectif était de traduire cette définition dans plusieurs langues européennes, dont le bulgare. 
Méthode : Une procédure Delphi adaptée avec traduction Aller/Retour a été utilisée. Une traduction de l’Anglais 
au Bulgare a été soumise par procédure Delphi à un panel d’experts bulgares en soins primaires. La traduction 
retour a été réalisée en aveugle de l’original. 
Résultats : Le panel d’experts répond aux critères d’inclusion. La traduction Bulgare a été validée unanimement 
au premier tour. La traduction retour en anglais a été produite. 
Discussion : Le choix d’une méthode de traduction Aller/Retour par procédure Delphi adaptée avec exigence sur 
la qualité du panel d’experts, garantit une traduction bulgare de la definition de la multimorbidité  fiable.  
 
Introduction : Patients coming to their family physician (FP) usually have more than one condition or problem. 
The World Health Organization (WHO) has simply 
 defined multimorbidity as two or more chronic conditions existing in one patient. However, this definition seems 
inadequate for a holistic approach to patient care within Family Medicine. Using systematic literature review the 
European 
 General Practitioners Research Network (EGPRN) developed a comprehensive definition of multimorbidity.  
Objective : For practical and wider use, this definition had to be translated into other languages, including 
Bulgarian. 
 
Method: A Delphi method adapted for a Forward-Backward translation was used.  The translation from English 
to Bulgarian was submitted by Delphi procedure to a panel of Bulgarian experts in primary care. Backward 
translation was performed with a blind back-translation principle. 
Results: The inclusion criteria of panel were kept. The Bulgarian translation was confirmed unanimously in one 
Delphi round. The Backward English translation was produced and agreed by the FPDM’s scientific committee. 
Discussion: The quality of the panel of experts FPs ensured a validated and reliable Bulgarian translation for the 
multimorbidity definition. 
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